CY1105526T1 - Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης - Google Patents

Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης

Info

Publication number
CY1105526T1
CY1105526T1 CY20061101108T CY061101108T CY1105526T1 CY 1105526 T1 CY1105526 T1 CY 1105526T1 CY 20061101108 T CY20061101108 T CY 20061101108T CY 061101108 T CY061101108 T CY 061101108T CY 1105526 T1 CY1105526 T1 CY 1105526T1
Authority
CY
Cyprus
Prior art keywords
pyridin
methynamine
intermediates
synthesis procedure
cyanohydrins
Prior art date
Application number
CY20061101108T
Other languages
English (en)
Inventor
Jean-Louis Maurel
Bernard Bonnaud
Jean-Paul Ribet
Bernard Vacher
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of CY1105526T1 publication Critical patent/CY1105526T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά μια νέα διαδικασία παρασκευής παραγώγων της πυριδιν-2-υλ-μεθυλαμίνης με αναγωγική δράση κυανοϋδρινών.
CY20061101108T 2001-02-09 2006-08-07 Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης CY1105526T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0101784A FR2820743B1 (fr) 2001-02-09 2001-02-09 Procede et intermediaires de synthese pour la preparation de derives de pyridin-2-yl-methylamine
PCT/FR2002/000508 WO2002064585A1 (fr) 2001-02-09 2002-02-11 Procede de synthese et intermediaires de pyridin-2-yl-methylamine

Publications (1)

Publication Number Publication Date
CY1105526T1 true CY1105526T1 (el) 2010-07-28

Family

ID=8859834

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101108T CY1105526T1 (el) 2001-02-09 2006-08-07 Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης

Country Status (12)

Country Link
US (1) US7208603B2 (el)
EP (1) EP1358179B1 (el)
JP (1) JP4259113B2 (el)
AT (1) ATE325794T1 (el)
CA (1) CA2437813C (el)
CY (1) CY1105526T1 (el)
DE (1) DE60211303T2 (el)
DK (1) DK1358179T3 (el)
ES (1) ES2263769T3 (el)
FR (1) FR2820743B1 (el)
PT (1) PT1358179E (el)
WO (1) WO2002064585A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2840900B1 (fr) * 2002-06-18 2005-02-25 Pf Medicament Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments
FR2891274B1 (fr) 2005-09-27 2007-11-23 Pierre Fabre Medicament Sa Procede de preparation du (3-chloro-4-fluoro-phenyl)-(4- fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}- piperidin-1-yl)-methanone et nouveaux derives pyrimidiniques intermediaires.
US8389534B2 (en) * 2008-05-19 2013-03-05 The University Of Tennessee Research Foundation Pyrimidine non-classical cannabinoid compounds and related methods of use
US8541431B2 (en) * 2008-05-19 2013-09-24 The University Of Tennessee Research Foundation Pyrimidine non-classical cannabinoid compounds and related methods of use
RU2702101C2 (ru) 2014-07-09 2019-10-04 Пьер Фабр Медикамент Способ лечения двигательных расстройств бефирадолом
CN105566214B (zh) * 2014-10-17 2020-05-15 上海医药工业研究院 3-[2-(3-氯苯基)乙基]-2-吡啶甲酸的制备工艺
US10626105B2 (en) 2016-09-22 2020-04-21 Auspex Pharmaceuticals, Inc. Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds
JP7401395B2 (ja) 2020-05-29 2023-12-19 ローム株式会社 基準電圧生成回路

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482437A (en) * 1984-04-05 1984-11-13 Reilly Tar & Chemical Corp. Electrochemical reductions of cyanopyridine bases
CA2241724A1 (en) * 1995-12-29 1997-07-10 Smithkline Beecham Corporation Vitronectin receptor antagonists
AU3461497A (en) * 1996-07-17 1998-02-09 Nippon Kayaku Kabushiki Kaisha Novel nitrogen monoxide synthetase inhibitors
FR2755967B1 (fr) * 1996-11-21 1999-01-29 Pf Medicament Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DE60211303D1 (de) 2006-06-14
JP4259113B2 (ja) 2009-04-30
CA2437813A1 (fr) 2002-08-22
FR2820743A1 (fr) 2002-08-16
DK1358179T3 (da) 2006-09-11
EP1358179B1 (fr) 2006-05-10
ATE325794T1 (de) 2006-06-15
EP1358179A1 (fr) 2003-11-05
JP2004519472A (ja) 2004-07-02
US20040116705A1 (en) 2004-06-17
CA2437813C (fr) 2011-04-19
DE60211303T2 (de) 2007-04-26
PT1358179E (pt) 2006-09-29
FR2820743B1 (fr) 2005-02-25
ES2263769T3 (es) 2006-12-16
US7208603B2 (en) 2007-04-24
WO2002064585A1 (fr) 2002-08-22

Similar Documents

Publication Publication Date Title
CY1105526T1 (el) Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
CY1109593T1 (el) Παραγωγα 12,13-κυκλοπροπανο εποθιλονης
CY1113105T1 (el) Παραγωγα ξανθινης, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1105575T1 (el) Ενωσεις αμιδιου και χρηση αυτων
CY1120765T1 (el) Βοηθημα για διευθετηση μαλλιων κατα διαφορετικους τυπους κομμωσης
CY1109276T1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
EA200300187A1 (ru) Способ получения n-арилантраниловых кислот и их производных
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
BR0209984A (pt) Processo para a preparação de prostaglandinas e seus análogos
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
HK1045990A1 (en) Novel derivatives and analogues of galanthamin.
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
BR0212390A (pt) Processo para a preparação de cilastatina
MXPA04000847A (es) Procedimiento para la obtencion de beraprost y sus sales.
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
ATE281827T1 (de) Verwendung von esterquats
PT1307436E (pt) Processo para a preparacao de derivados de bacatina iii
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona